Hydrothermal synthesis, crystal structure, and photoluminescence of Pb(II) and Mn(II) coordination polymers based on imidazo[4,5-f][1,10]phenanthroline

Two new coordination polymers, [Pb(IDPT)₂(NO₃)₂] (I) and [Mn(IDPT)(SO₄)(H₂O)₂] (II) (IDPT = imidazo[4,5-f][1,10]phenanthroline), were synthesized by hydrothermal method and characterized by elemental analysis and single-crystal X-ray diffraction technique. The results reveal that the complex I belongs to monoclinic crystal system, space group C2/c and complex II belongs to monoclinic crystal system, P2₁/c space group. The cell parameters are: a = 19.1970(13), b = 7.3875(5), c = 17.3825(12) Å, β = 100.47(10)°, V = 2424.0(3) ų, Z = 4, F(000) = 1488 for I; a = 10.9135(6), b = 7.0230(4), c = 19.7034(10) Å, β = 99.32(10)°, V = 1490.25(14) ų, Z = 4, F(000) = 828 for II. In the structure of complex I, the metal center Pb(II) is six-coordinated, displays an octahedral geometry. Each molecule is further connected with neighboring one via π-π interactions into 1D chain. In complex II, Mn(II) is six-coordinated to form a distorted octahedral geometry. Compound II displays 1D supramolecular chain formed through hydrogen bonds. Additionally, the fluorescent properties for the complexes were investigated. Complexes I and II exhibit strong photoluminescence with emission maximum at 583 and 529 nm at room temperature.     

Acid Co(II) and Ni(II) trifluoroacetate complexes: Synthesis and crystal structure

Anhydrous and partially hydrated acid trinuclear trifluoroacetates of divalent transition metals of the composition [M₃(CF₃COO)₆(CF₃COOH)₆)](CF₃COOH) and [M₃(CF₃COO)₆(CF₃COOH)₂(H₂O)₄)](CF₃COOH)₂, respectively, where M = Co (I, III) Ni (II, IV), were synthesized and studied by X-ray diffraction. Complexes I and II were obtained by crystallization from solutions of M(CF₃COO)₂ · 4H₂O in trifluoroacetic anhydride; complexes III and IV were synthesized under the same conditions with the use of 99% trifluoroacetic acid as a solvent. Crystals I are triclinic: space group $P\bar 1$ , a = 13.199(6) Å, b = 14.649(6) Å, c = 15.818(6) Å, α = 90.04(4)°, β = 114.32(4)°, γ = 108.55(4)°, V = 2611.3(19) ų, Z = 2, R = 0.0480. Crystals II are trigonal: space group $R\bar 3$ , a = 13.307(2) Å, c = 53.13(1) Å, V = 8148(2) ų, Z = 6, R = 0.1112. Crystals III are triclinic: space group $P\bar 1$ , a = 9.001(8) Å, b = 10.379(9) Å, c = 12.119(9) Å, α = 83.67(5)°, β = 72.33(5)°, γ = 83.44(5)°, V = 1068.3(15) ų, Z = 1 Å, R = 0.1031. Crystals IV are triclinic: space group $P\bar 1$ , a = 9.121(18) Å, b = 10.379(2) Å, c = 12.109(2) Å, α = 84.59(3)°, β = 72.20(3)°, γ = 82.80(3)°, V = 1080.94(40) ų, Z = 1, R = 0.0334.     

Diaquabromo(18-crown-6)rubidium and triaqua(18-crown-6)barium dibromide monohydrate: Synthesis and crystal structures

Two complexes are synthesized: diaquabromo(18-crown-6)rubidium [RbBr(18-crown-6)(H₂O)₂] (I) and triaqua(18-crown-6)barium dibromide monohydrate [Ba(18-crown-6)(H₂O)₃]²⁺ 2Br^? · H₂O (II). The orthorhombic structure of compound I (space group Pnma, a = 10.124 Å, b = 15.205 Å, c = 12.544 Å, Z = 4) and the monoclinic structure of compound II (space group C 2/c, a = 17.910 Å, b = 10.315 Å, c = 14.879 Å, β = 123.23°, Z = 4) are determined by a direct method and refined by the full-matrix least-squares method in the anisotropic approximation to R = 0.063 (I) and 0.042 (II) for all 2293 (I) and 3363 (II) independent measured reflections (CAD-4 automated diffractometer, λMoK _α). The complex molecule [RbBr(18-crown-6)(H₂O)₂] in compound I and the randomly disordered cation [Ba(18-crown-6)(H₂O)₃]²⁺ in compound II are of the host-guest type: their Rb⁺ or Ba²⁺ cation (its coordination number is nine) is located in the cavity of the 18-crown-6 ligand and coordinated by all six O atoms. In structure I, the coordination polyhedron of Rb⁺ is a distorted hexagonal pyramid with a triple apex at the Br^? ligand and two O atoms of the water molecules. In structure II, the Ba²⁺ polyhedron is a distorted hexagonal bipyramid with one apex at the O atom of the water molecule and the other split apex at two O atoms of water molecules.     

Synthesis and study of tetraamminecobalt hydrogen hexamolybdometalates(III)

Tetraamminecobalt hydrogen hexamolybdoferrate [Co(NH₃)₄] · H[FeMo₆O₁₈(OH)₆] · 6H₂O (I) and tetraamminecobalt hydrogen hexamolybdogallate(III) [Co(NH₃)₄] · H[GaMo₆O₁₈(OH)₆] · 6H₂O (II) were synthesized and studied by mass spectrometry, thermogravimetry, IR spectroscopy, and X-ray diffraction. Crystals of I and II are monoclinic; a = 16.21 Å, b = 5.43 Å, c = 12.32 Å, β = 119.63°, V = 1092.11 ų, ρ_calcd = 2.21 g/cm³, and Z = 1 for I; a = 16.24 Å, b = 5.59 Å, c = 12.29 Å, β = 119.79°, V = 1064.05 ų, ρ_calcd = 2.15 g/cm³, and Z = 1 for II. Compounds I and II were used as catalysts for soft oxidation of natural gas.     

Synthesis and crystal structures of binuclear complexes of cobalt(II) and cadmium(II) diisobutyldithiophosphinates with hexamethylenetetramine

Heteroligand complexes [Co₂(HMTA)(iso-Bu₂PS₂)₄] (I) (μ_eff = 4.67 μB) and [Cd₂(HMTA)(iso-Bu₂PS₂)₄] (II) have been synthesized. Single crystals of compounds I and II have been obtained. The crystals are monoclinic: a = 32.622(2) Å, b = 9.4891(6) Å, c = 21.7570(13) Å, β = 125.774(1)^o, V = 5464.3(6) Å,³, Z = 4, ρ_calcd = 1.331 g/cm³ for I; a = 34.6092(7) Å, b = 9.5595(2) Å, c = 22.3473(5) Å, β = 127.144(1)^o, V = 5893.5(2) Å, Z = 4, ρ_calcd = 1.355 g/cm³ for II; space group for both complexes C2/c. Structures I and II are based on discrete binuclear molecules. The coordination polyhedra of the Co and Cd atoms are distorted tetragonal pyramids NS₄, with the bases formed by four S atoms of two bidentate chelating ligand iso-Bu₂PS ₂ ^? and the axial vertices occupied by N atoms of bidentate bridging HMTA ligand. The character of interaction of the molecules in structures I and II is considered.     

Coordination molecular compounds of cadmium(II) iodide with dimethylpyridines

The reactions of CdI₂ with dimethylpyridines (Me₂Py is C₇H₉N) afford complexes CdI₂(2,3-Me₂Py)₂] (I), [CdI₂(2,6-Me₂Py) (II), and CdI₂(3,5-Me₂Py)₂ (III). The structures of compounds I and II are determined. The crystals of complex I are orthorhombic, space group Pbca, a = 7.930(1) Å, b = 15.537(1) Å, c = 29.943(1) Å, V = 3689.1(5) ų, ρ_calcd = 2.090 g/cm³, Z = 8. The crystals of complex II are monoclinic, space group C2/c, a = 14.784(1), b = 11.991(1), c = 17.711(1) Å, β = 90.39(1)°, V = 1081.1(2) ų, ρ_calcd = 2.908 g/cm³, Z = 4. The structure of compound I is built of discrete neutral complexes [CdI₂(2,3-Me₂Py)₂]. The Cd polyhedron is a distorted tetrahedron (Cd-I 2.289–2.295, Cd-N 2.708–2.734 Å, angles N(I)CdN(I) 103.1°-114.8°). Polymer chains [CdI₂(2,6-Me₂Py)]_∞ extended along the direction [100] are observed due to the bridging iodine atoms in structure II. The Cd polyhedron is a trigonal bipyramid containing iodine atoms at the axial vertices (Cd-I_aks 3.040 Å) and two iodine atoms and the nitrogen atom of the Me₂Py ligand in the equatorial plane Me₂Py (Cd-I_eq 2.840 Å, Cd-N 2.309 Å). The compounds in the solid state are photoluminescent.     

Cadmium(II) iodide molecular coordination compounds with 4-methylpyridine and 4-methylquinoline

The coordination compounds [CdI₂(4-MePy)₂] (I) and [CdI₂(4-MeQuin)₂] (II) where Quin is quinoline have been synthesized, and their structure has been solved. Crystals of complex I are monoclinic, space group C2/c, a = 13.353(1) Å, b = 16.653(1) Å, c = 14.380 (1) Å, β = 103.17(1)°, V = 3113.5(4) ų, ρ_calcd = 2.425 g/cm³, Z = 8. Crystals of complex II are monoclinic, space group P2₁/c, a = 10.647(1) Å, b = 25.264(1) Å, c = 8.610(1) Å, β = 113.73(1)°, V = 2120.1(3) ų, ρ_calcd = 2.044 g/cm³, Z = 4. Polymer [CdI₂(4-MePy)₂]_∞ chains running in the direction [001] are formed in the structure of complex I. Each of the two crystallographically nonequivalent Cd(1) and Cd(2) atoms are octahedrally surrounded by the four iodine and two nitrogen atoms of the 4-MePy ligand. The Cd(1)?Cd(2) distance in a chain is 4.33 Å. The structure of complex II is built of [CdI₂(4-MeQuin)₂] discrete neutral clusters. The two iodine and two nitrogen atoms of the 4-MeQuin ligand participate in the coordination of the Cd²⁺ ion. The cadmium coordination polyhedron is a distorted tetrahedron (Cd-I_avg, 2.72 Å; Cd-N_avg, 2.30 Å; angles N(I)CdN(I), 98.3–121.8°). The minimum and maximum values correspond to the ICdI angle and NCdN angle, respectively. Complex I is photoluminescent in the solid state at room temperature.     

Synthesis and crystal structure of zinc(II) and manganese(II) complexes of 2-(diphenylacetyl)indandione-1,3

Zinc(II) and manganese(II) complexes of 2-(diphenylacetyl)indandione-1,3 (HL) were synthesized. Crystals of [M(DMSO)₂L₂] · CHCl₃, where M= Zn^(II) (I) and Mn^(II) (II), obtained from chloroform plus dimethyl sulfoxide (DMSO) mixture were found to be isostructural based on the similarity of their unit cell parameters and unit cell volumes. The crystals are triclinic, Z = 2, space group P \(\bar 1\); a = 10.422(1) Å, b = 11.929(1) Å, c = 20.429(1) Å, α = 73.616(1)°, β = 85.095(1)°, γ = 77.586(1)° for complex I; a = 10.436(1) Å, b = 12.297(1) Å, c = 19.924(2) Å, α = 78.138(2)°, β = 87.625(2)°, γ = 82.048(2)° for complex II. X-ray structural analysis of complex I was carried out. For complex II, the structure was not refined because all of its atoms are each disordered over three to five positions. The two DMSO molecules in complex I coordinate the central metal atoms in the monodentate mode via their donor oxygen atoms to occupy an axial position and an equatorial position in an octahedral polyhedron. The other four positions are occupied by the four oxygen atoms of the two deprotonated ligands L^? coordinated in the bidentate-cyclic mode. The outer sphere of complex I contains the solvating chloroform molecule.     

Crystal structure of adducts of copper(II) acetylacetonate and hexafluoroacetylacetonate with 4-aminopyridine

Single crystal X-ray diffraction is used to investigate two synthesized β-diketonate complexes of copper(II) with aminopyridine: Cu(4-NH₂Py)(aa)₂ (I) and Cu(4-NH₂Py)(hfa)₂ (II). The crystals of I and II have a monoclinic system; the unit cell parameters of I are: P2₁/n space group, a = 8.2921(3) Å, b = 14.7243(5) Å, c = 13.4970(4) Å, β = 102.426(1)°, V = 1609.32(9) ų, Z = 4; for II: C2/c space group, a = 23.5704(5) Å, b = 11.4977(2) Å, c = 16.0285(3) Å, β = 109.265(1)°, V = 4100.6(1) ų, Z = 8. The structures of I and II are molecular; they are composed of isolated molecules. The coordination polyhedron of the copper atom is formed by the O atoms of two acetylacetonate ligands (Cu-O 1.940(2)–2.171(2) I and the O atoms of two hexafluoroacetylacetonate ligands (Cu-O 1.940(2)–2.215(3) Å) in II. The molecules of 4-NH₂Py are bonded to the copper atom via the nitrogen atom of the aromatic ring (Cu-N 2.008(2) Å in I and Cu-N 1.978(3) Å in II). Noncoordinated amino groups join the molecules of the complexes together by means of N-H…O hydrogen bonds.     

Synthesis and crystal structures of two azido-bridged copper(II) complexes with schiff bases

Two new end-on azido-bridged dinuclear copper(II) complexes with the formula [Cu(μ_1,1-N₃)₂(IEP)₂] (I) and [Cu(μ_1,1-N₃)₂(EMP)₂] (II), where IEP and EMP are the deprotonated forms of 2-[1-(2-isopropylaminoethylimino)ethyl]phenol and 2-ethoxy-6-[(2-methylaminoeth-ylimino)methyl]phenol, respectively, were synthesized. Both complexes were characterized by elemental analyses and IR spectra. The crystal structures were determined by the X-ray diffraction. The crystal of I is monoclinic: space group P2₁/c, a = 9.662(2), b = 15.282(3), c = 10.639(2) Å, β = 115.418(10)°, V = 1418.9(5) ų, Z = 2. The crystal of II is monoclinic: space group P2₁/n, a = 12.588(2), b = 7.705(1), c = 14.481(2), β = 91.736(5)°, V = 1403.9(2) ų, Z = 2. The two Cu atoms in each complex are bridged by two end-on azide groups. Each Cu atom is in a square pyramidal coordination. The Cu…Cu distances are 3.230(2) Å in I and 3.150(2) Å in II.     

Synthesis,crystal structures,and biological property of dinuclear oxovanadium(V) complexes derived from tridentate Schiff bases

A pair of structurally similar dinuclear oxovanadium(V) complexes, [VO₂L¹]₂ (I) and [VO₂L²]₂ (II), where L¹ and L² are the mono-anionic form of 2-[(2-isopropylaminoethylimino)methyl]-4-methylphenol (HL¹) and 4-fluoro-2-[(2-isopropylaminoethylimino)methyl]phenol (HL²), respectively, have been synthesized and characterized by elemental analysis, FT-IR spectra, and single crystal X-ray determination. The crystal of I is monoclinic: space group P2₁/c, a = 12.528(1), b = 12.266(1), c = 9.432(1) Å, β = 104.814(3)°, V = 1401.2(3) ų, Z = 2. The crystal of I is monoclinic: space group P2₁/n, a = 12.3128(5), b = 6.5124(3), c = 17.1272(7) Å, β = 105.863(1)°, V = 1321.1(1) ų, Z = 2. The V…V distances are 3.210(1) Å in I and 3.219(1) Å in II. The V atoms in the complexes are in octahedral coordination. Biological assay indicates that complex II, bearing fluoro-substitute groups, has stronger antimicrobial activity against most bacteria than complex I which bearing methyl-substitute groups.     

Synthesis and structure of lithium and rubidium compounds with 2-(diphenylacetyl)-1,3-indanedione

Complexes RbL (I) and [Li₂(C₂H₅OH)L₂] (II) (L = C₂₃H₁₅O₃) have been synthesized and their crystal structures have been studied. Both compounds have monoclinic crystals with space group P2₁/c and Z = 4; I: a = 11.632(2) Å, b = 15.154(3) Å, c = 11.457(2) Å, β = 104.34(3)°; II: a = 12.982(3)Å, b = 12.083(2) Å, c = 25.317(5) Å β = 100.11(3)°. In the structure of I, dimeric groups [Rb₂O₆] with a shared edge are linked by the ligands to give infinite layers perpendicular to the x axis and cavities that form oblong channels. In the structure of II, Li₂O₇ dimers are formed by vertex sharing. The coordination of one of the lithium atoms (Li(1)) is completed to tetrahedral by the oxygen atom of the ethanol molecule. The structure of II, like that of I, is layered.     

Copper(II) and lead(II) complexes based on 2,3,5,6-tetrakis(2-pyridyl)pyrazine as a polydentate ligand

The Cu(II) complexes [Cu(Tppz)(Dipic)] · 8H₂O (I) and [Pb₂(Tppz)Cl₄] _n (II), where Tppz, H2Dipic are 2,3,5,6-tetrakis(2-pyridyl)pyrazine, dipicolinic acid, respectively, have been synthesized and characterized by elemental analyses, IR, cyclic voltammetry, and electronic spectral studies. Solid state structures of both complexes have been determined by single crystal X-ray crystallography. An ORTEP drawing of two complexes shows that the coordination geometry around the metal center is a distorted octahedron. There are extensive conventional intermolecular O-H…O, N-H…O, and weaker C-H…O and C-H…Cl non-classical hydrogen bonds, which cause the stability of the crystal structure. Crystal data for I: monoclinic, space group: C2/c, a = 35.421(3), b = 8.422(6), c = 22.824(8) Å, β = 101.69(2)°, V = 6668(5) ų, Z = 8. Crystal data for II: triclinic, space group P \(\bar 1\) , a = 7.9534(4), b = 8.8682(5), c = 9.4245(5) Å, β = 95.086(2)°, V = 655.93(6) ų, Z = 2.     

New complex ytterbium molybdophosphates M 2 I Yb(PO4)(MoO4) (MI = K, Na): Synthesis and structure solution

Complex rare-earth molybdophosphates of sodium and potassium (Na₂Yb(PO₄)(MoO₄) (I) and K₂Yb(PO₄)(MoO₄) (II) are synthesized by solid-phase reactions at 600°C (for I) and 750°C (for II). The molybdophosphates are characterized using powder X-ray diffraction, laser second harmonic generation (SHG), IR spectroscopy, and differential thermal analysis. Their structures are refined using the Rietveld technique. The compounds are isostructural and crystallize in an orthorhombic system (space group Ibca, Z = 8). The unit cell parameters are a = 18.0086(1) Å, b = 12.0266(1) Å, c = 6.7742(1) Å for compound I and a = 19.6646(1) Å, b = 12.0570(1) Å, c = 6.8029(1) Å for compound II. The structures are built of YbO₈ chains extended along axis c and linked into layers through PO₄ tetrahedra. The Na⁺ cations (CN = 6) and the K⁺ cations (CN = 8) reside in the interlayer spaces.     

Crystal structures of nitrato-{4-bromo-2-[(2-hydroxyethylimion)methyl]phenolo}-(3,5-Dibromopyridine)copper and nitrato-{2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper

The crystal structures of nitrato-{4-bromo-2-[2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper (I) and nitrato-{2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper (II) are determined. The crystals of compound I are orthorhombic: a = 14.157(3) Å, b = 15.420(3) Å, c = 17.494(4) Å, space group Pbca, Z = 8, R = 0.067. The crystals of compound II are monoclinic: a = 10.675 Å, b = 13.973 Å, c = 14.007 Å, β = 111.92°, space group P2₁/n, Z = 4, R = 0.0464. In the structures of compounds I and II, the copper atom coordinates, correspondingly, singly deprotonated 4-bromo-2-[(2-hydroxyethylimino)methyl]phenol and 2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenol molecules, and 3,5-dibromopyridine, and the nitrate ion. The coordination polyhedron of the copper ion in complexes I and II is a slightly distorted tetragonal pyramid. The bases of the pyramids are formed by the imine and pyridine nitrogen atoms and the phenolic and alcoholic oxygen atoms, and the axial vertices are occupied by the oxygen atoms of the monodentate nitrato groups. In the complexes under study, the six-membered metallocycles have asymmetric gauche conformation. In crystal, complexes I are united, due to the slip plane a, through bifurcate hydrogen bonds into infinite chains along the direction [100]. Complexes II in crystal form two-dimensional networks by means of hydrogen bonds.     

Synthesis and crystal structures of cobalt(III) and zinc(II) complexes derived from 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol with urease inhibitory activity

A new mononuclear cobalt(III) complex, [CoL₂(N₃)]₂ · CH₃OH (I), and a new mononuclear zinc(II) complex, [ZnLCl(CH₃OH)] (II) (HL = 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol), were prepared and structurally characterized by elemental analyses, infrared spectroscopy, and single- crystal X-ray diffraction. The crystal of I is monoclinic: space group P2₁/c, a = 18.742(2) Å, b = 15.197(2) Å, c = 25.646(2) Å, β = 125.996(3)°, V = 5909.8(11) ų, Z = 4. The crystal of II is monoclinic: space group P2₁/c, a = 7.257(1) Å, b = 24.707(2) Å, c = 9.637(1) Å, β = 101.557(2)°, V = 1692.9(3) ų, Z = 4. The Co atom in I is in an octahedral coordination, and the Zn atom in II is in a trigonal-bipyramidal coordination. The urease inhibitory test shows that complex I has strong urease inhibitory activity, while complex II has no activity.     

Synthesis and crystal structures of Manganese(IV) complexes with tridentate schiff bases

The complexes with the formulae [Mn(L¹)₂] · 0.5H₂O (I) and [Mn(L²)₂] (II), where L¹ and L² are the dianionic form of 2,4-dichloro-6-[(2-hydroxyethylimino)methyl]phenol and 2-{[1-(3-ethoxy-2-hydroxyphenyl)methylidene]amino}-2-methylpropane-1,3-diol, respectively, were obtained and characterized by elemental analysis and IR spectroscopy. The crystal structures of complexes I and II were determined using X-ray diffraction. The crystal of I is orthorhombic space group Fdd2: a = 24.170(2), b = 32.021(3), c = 11.352(2) Å, V = 8785.9(19) ų, Z = 8. The crystal of II is monoclinic space group C2/c: a = 13.931(4), b = 18.381(5), c = 12.444(5) Å, β = 121.980(3)°, V = 2702.9(15) ų, Z = 4. The Mn atom in each of the complexes is in an octahedral coordination.     

Synthesis and crystal structure of Mn(II) and Hg(II) compounds and solution studies of Mn(II), Zn(II), Cd(II) and Hg(II) compounds based on piperazinediium pyridine-2,3-dicarboxylate

Novel metal organic frameworks including {(pipzH₂)[Mn(py-2,3-dc)₂]·7.75H₂O}_n, 1, {(pipzH₂)[Zn(py-2,3-dc)₂]·4H₂O}_n, 2, [Cd(py-2,3-dc)(H₂O)₃]_n, 3 and {(pipzH₂)[Hg₄Cl₁₀]}_n, 4, in which pipz is piperazine and py-2,3-dcH₂ is pyridine-2,3-dicarboxylic acid were synthesized applying a proton transfer ion pair i.e. (pipzH₂)(py-2,3-dcH)₂ and corresponding metallic salts and studied by IR, ¹H NMR, ¹³C NMR spectroscopy and single crystal X-ray diffractometry. The space group of compounds 1 and 4 are P2₁/c and C2/c of monoclinic system, respectively. The crystal dimensions are a = 20.108(2) Å, b = 19.910(2) Å, c = 12.997(1) Å, β = 94.354(2)° for 1 and a = 15.940(1) Å, b = 11.2690(9) Å, c = 11.1307(9) Å, β = 90.685(2)° for 4. The crystal structures of 2 and 3 have been reported previously. However, their solution studies are discussed here. The compounds had all polymeric structures. Although Zn^II, Cd^II and Hg^II were elements of the same group, their behavior against the ion pair was essentially different. Various supramolecular interactions mainly hydrogen bonds of the type O-H?O, N-H?O, C-H?O, N-H…Cl and C-H?Cl were observed in the structures. There was an unusual and huge water cluster in the structure of compound 1. The solution states of compounds 1–4 were studied and reported. The protonation constants of pipz and py-2,3-dc, the py-2,3-dc/pipz proton transfer equilibrium constants and stoichiometry and stability of the system with Mn²⁺, Zn²⁺, Cd²⁺ and Hg²⁺ ions in aqueous solution were investigated by potentiometric pH titrations.     

Syntheses, crystal structures, and fluorescence properties of Zinc(II) complexes with multi-dentate Schiff bases

Two new structurally similar mononuclear Schiff base zinc(II) complexes, [ZnBr(ClMP)] (I) and [ZnCl(NMP)] (II) (ClMP = 4-chloro-2-[(3-morpholin-4-ylpropylimino)methyl]phenolate; NMP = 4-nitro-2-[(3-morpholin-4-ylpropylimino)methyl]phenolate), and two new dinuclear Schiff base zinc(II) complexes, [Zn₂(EMP)₂I₂] (III), and [Zn₂(MPA)(CH₃OH)₂(N₃)₂] (IV) (EMP = 5-diethylamino-2-[(2-dimethylaminoethylimino)methyl]phenolate; MPA = N,N′-bis(3-methoxysalicylidene)propane-1,3-diamine), have been prepared and characterized mainly by single-cyrstal X-ray diffraction. Complex I crystallizes in the monoclinic space group P2₁/n with unit cell dimensions: a = 15.116(3), b = 9.465(1), c = 23.714(4) Å, β = 104.358(2)°, V = 3286.9(8) ų, Z = 8, R ₁ = 0.0439, and wR ₂ = 0.0736. Complex II crystallizes in the monoclinic space group P2₁/c with unit cell dimensions: a = 7.253(2), b = 16.652(4), c = 13.568(3) Å, β = 96.600(2)°, V = 1627.8(6) ų, Z = 4, R ₁ = 0.0417, and wR ₂ = 0.0809. Complex III crystallizes in the monoclinic space group C2/c with unit cell dimensions: a = 27.962(2), b = 8.246(2), c = 31.605(3) Å, β = 90.343(2)°, V = 7287.4(15) ų, Z = 8, R ₁ = 0.0721, and wR ₂ = 0.1709. Complex IV crystallizes in the monoclinic space group C2/c with unit cell dimensions: a = 20.483(3), b = 11.344(2), c = 14.909(3) Å, β = 131.650(1)°, V = 2588.6(7) ų, Z = 4, R ₁ = 0.0343, and wR ₂ = 0.0792. Each Zn atom in I and II are four-coordinated in a tetrahedral geometry by the NNO donor set of the Schiff base ligand and one halide atom. The Zn atoms in III are in square pyramidal coordination, and those in IV are in octahedral and tetrahedral coordination. Thermal stability and fluorescence properties of the complexes I and II have also been determined.     

Crystal structures of allyltriphenyl-phosphonium halogenocuprates(I)

Alternating-current electrochemical synthesis is used to obtain for the first time halogenocuprates of an allyl derivative of phosphonium of the composition (CH₂=CHCH₂(C₆H₅)₃P)CuX₂ (X = Br (I), Cl (II)). Compound I crystallizes in the space group P2₁, a = 9.6341(3) Å, b = 12.4167(4) Å, c = 9.9618(4) Å, β = 117.484(5)°, Z = 2. Compound II crystallizes in the space group P2₁/n, a = 9.9725(5) Å, b = 15.4586(8) Å, c = 13.7557(5) Å, β = 90.429(4)°, Z = 4. In the structures of I and II quasilinear CuX ₂ ^? anions are held by C-H…X hydrogen bonds inside a framework formed by the stacking of phenyl groups from CH₂=CHCH₂(C₆P₅)₃P⁺ cations. Allyl groups are not involved in coordination with copper(I) atoms.